309 related articles for article (PubMed ID: 31584114)
1. Impact of matrix effects and ionization efficiency in non-quantitative untargeted metabolomics.
Chamberlain CA; Rubio VY; Garrett TJ
Metabolomics; 2019 Oct; 15(10):135. PubMed ID: 31584114
[TBL] [Abstract][Full Text] [Related]
2. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis.
Matuszewski BK
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):293-300. PubMed ID: 16310419
[TBL] [Abstract][Full Text] [Related]
3. Validation of a dual LC-HRMS platform for clinical metabolic diagnosis in serum, bridging quantitative analysis and untargeted metabolomics.
Gertsman I; Gangoiti JA; Barshop BA
Metabolomics; 2014 Apr; 10(2):312-323. PubMed ID: 25411574
[TBL] [Abstract][Full Text] [Related]
4. Method selectivity evaluation using the co-feature ratio in LC/MS metabolomics: Comparison of HILIC stationary phase performance for the analysis of plasma, urine and cell extracts.
Elmsjö A; Haglöf J; Engskog MKR; Erngren I; Nestor M; Arvidsson T; Pettersson C
J Chromatogr A; 2018 Sep; 1568():49-56. PubMed ID: 29789170
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
Jemal M; Schuster A; Whigan DB
Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
[TBL] [Abstract][Full Text] [Related]
6. The co-feature ratio, a novel method for the measurement of chromatographic and signal selectivity in LC-MS-based metabolomics.
Elmsjö A; Haglöf J; Engskog MK; Nestor M; Arvidsson T; Pettersson C
Anal Chim Acta; 2017 Mar; 956():40-47. PubMed ID: 28093124
[TBL] [Abstract][Full Text] [Related]
7. Matrix removal in state of the art sample preparation methods for serum by charged aerosol detection and metabolomics-based LC-MS.
Schimek D; Francesconi KA; Mautner A; Libiseller G; Raml R; Magnes C
Anal Chim Acta; 2016 Apr; 915():56-63. PubMed ID: 26995640
[TBL] [Abstract][Full Text] [Related]
8. A validated multi-matrix platform for metabolomic fingerprinting of human urine, feces and plasma using ultra-high performance liquid-chromatography coupled to hybrid orbitrap high-resolution mass spectrometry.
De Paepe E; Van Meulebroek L; Rombouts C; Huysman S; Verplanken K; Lapauw B; Wauters J; Hemeryck LY; Vanhaecke L
Anal Chim Acta; 2018 Nov; 1033():108-118. PubMed ID: 30172316
[TBL] [Abstract][Full Text] [Related]
9. Matrix effects break the LC behavior rule for analytes in LC-MS/MS analysis of biological samples.
Fang N; Yu S; Ronis MJ; Badger TM
Exp Biol Med (Maywood); 2015 Apr; 240(4):488-97. PubMed ID: 25304311
[TBL] [Abstract][Full Text] [Related]
10. Metabolic phenotype of the healthy rodent model using in-vial extraction of dried serum, urine, and cerebrospinal fluid spots.
Sen A; Wang Y; Chiu K; Whiley L; Cowan D; Chang RC; Legido-Quigley C
Anal Chem; 2013 Aug; 85(15):7257-63. PubMed ID: 23845063
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography coupled to tandem mass spectrometry for the residue determination of ethylenethiourea (ETU) and propylenethiourea (PTU) in water.
Ripollés C; Sancho JV; López FJ; Hernández F
J Chromatogr A; 2012 Jun; 1243():53-61. PubMed ID: 22578799
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical cluster analysis of technical replicates to identify interferents in untargeted mass spectrometry metabolomics.
Caesar LK; Kvalheim OM; Cech NB
Anal Chim Acta; 2018 Aug; 1021():69-77. PubMed ID: 29681286
[TBL] [Abstract][Full Text] [Related]
13. An optimized LC-HRMS untargeted metabolomics workflow for multi-matrices investigations in the three-spined stickleback.
Lebeau-Roche E; Daniele G; Fildier A; Turies C; Dedourge-Geffard O; Porcher JM; Geffard A; Vulliet E
PLoS One; 2021; 16(11):e0260354. PubMed ID: 34843526
[TBL] [Abstract][Full Text] [Related]
14. Improving data quality in liquid chromatography-mass spectrometry metabolomics of human urine.
Burgos RCR; de Macedo AN; da Cruz PLR; Tedesco-Silva Júnior H; Cardozo KHM; Carvalho VM; Tavares MFM
J Chromatogr A; 2021 Sep; 1654():462457. PubMed ID: 34404016
[TBL] [Abstract][Full Text] [Related]
15. Ionization Suppression and Recovery in Direct Biofluid Analysis Using Paper Spray Mass Spectrometry.
Vega C; Spence C; Zhang C; Bills BJ; Manicke NE
J Am Soc Mass Spectrom; 2016 Apr; 27(4):726-34. PubMed ID: 26729455
[TBL] [Abstract][Full Text] [Related]
16. The ABRF Metabolomics Research Group 2013 Study: Investigation of Spiked Compound Differences in a Human Plasma Matrix.
Cheema AK; Asara JM; Wang Y; Neubert TA; Tolstikov V; Turck CW
J Biomol Tech; 2015 Sep; 26(3):83-9. PubMed ID: 26290656
[TBL] [Abstract][Full Text] [Related]
17. Patterned Signal Ratio Biases in Mass Spectrometry-Based Quantitative Metabolomics.
Yu H; Huan T
Anal Chem; 2021 Feb; 93(4):2254-2262. PubMed ID: 33400486
[TBL] [Abstract][Full Text] [Related]
18. Development of an Untargeted LC-MS Metabolomics Method with Postcolumn Infusion for Matrix Effect Monitoring in Plasma and Feces.
Zhu P; Dubbelman AC; Hunter C; Genangeli M; Karu N; Harms A; Hankemeier T
J Am Soc Mass Spectrom; 2024 Mar; 35(3):590-602. PubMed ID: 38379502
[TBL] [Abstract][Full Text] [Related]
19. Enhancing coverage in LC-MS-based untargeted metabolomics by a new sample preparation procedure using mixed-mode solid-phase extraction and two derivatizations.
Wu Q; Xu Y; Ji H; Wang Y; Zhang Z; Lu H
Anal Bioanal Chem; 2019 Sep; 411(23):6189-6202. PubMed ID: 31414155
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
